Correlation Between Cingulate Warrants and NLS Pharmaceutics

Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and NLS Pharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and NLS Pharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cingulate Warrants and NLS Pharmaceutics AG, you can compare the effects of market volatilities on Cingulate Warrants and NLS Pharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of NLS Pharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and NLS Pharmaceutics.

Diversification Opportunities for Cingulate Warrants and NLS Pharmaceutics

0.19

Correlation Coefficient

Cingulate Warrants  NLS Pharmaceutics

Average diversification

The 3 months correlation between Cingulate and NLS is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and NLS Pharmaceutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NLS Pharmaceutics and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with NLS Pharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NLS Pharmaceutics has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and NLS Pharmaceutics go up and down completely randomly.

Pair Corralation between Cingulate Warrants and NLS Pharmaceutics

Assuming the 90 days horizon Cingulate Warrants is expected to generate 2.79 times less return on investment than NLS Pharmaceutics. But when comparing it to its historical volatility, Cingulate Warrants is 1.26 times less risky than NLS Pharmaceutics. It trades about 0.02 of its potential returns per unit of risk. NLS Pharmaceutics AG is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  1.00  in NLS Pharmaceutics AG on September 16, 2024 and sell it today you would lose (0.20) from holding NLS Pharmaceutics AG or give up 20.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	95.24%
Values	Daily Returns

Cingulate Warrants  vs.  NLS Pharmaceutics AG

Cingulate Warrants

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cingulate Warrants has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable technical and fundamental indicators, Cingulate Warrants is not utilizing all of its potentials. The recent stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

NLS Pharmaceutics

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in NLS Pharmaceutics AG are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, NLS Pharmaceutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cingulate Warrants and NLS Pharmaceutics

The main advantage of trading using opposite Cingulate Warrants and NLS Pharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, NLS Pharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will offset losses from the drop in NLS Pharmaceutics' long position.

The idea behind Cingulate Warrants and NLS Pharmaceutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.